Format

Send to

Choose Destination
Vaccine. 2019 Feb 28;37(10):1374-1376. doi: 10.1016/j.vaccine.2019.01.038. Epub 2019 Feb 4.

Corrigendum to 'A report on the status of vaccination in Europe' [Vaccine 36 (2018) 4979-4992].

Author information

1
GSK, Avenue Fleming 20, 1300 Wavre, Belgium. Electronic address: shazia.x.sheikh@gsk.com.
2
Deloitte Belgium, Luchthaven Nationaal 1 J, 1930 Zaventem, Belgium.
3
GSK, Avenue Fleming 20, 1300 Wavre, Belgium.
4
Department of Health Economics and Health Care Management, School of Public Health, Bielefeld University, Universitätsstraße 25, 33615 Bielefeld, Germany.
5
Université Paris Descartes, Sorbonne Paris Cité, Inserm CIC 1417, Assistance Publique Hopitaux de Paris (APHP), CIC Cochin-Pasteur, rue du Faubourg St Jacques 27, 75679 Paris cedex 14, France.
6
GSK, Great West Road 980, Brentford TW8 9GS, UK.
7
Institute of Public Health, Università Cattolica del Sacro Cuore, Largo Francesco Vito 1, 00168 Rome, Italy.
8
Unit of PharmacoTherapy, -Epidemiology & -Economics, University of Groningen, Groningen Research Institute of Pharmacy, Antonius Deusinglaan 1, 9713 AV Groningen, the Netherlands; Department of Health Sciences, University of Groningen, University Medical Center Groningen, Antonius Deusinglaan 1, 9713 AV Groningen, the Netherlands; Department of Economics, Econometrics & Finance, University of Groningen, Faculty of Economics & Business, Groningen, the Netherlands.
9
European Center of Pharmaceutical Medicine, University of Basel, Klingelbergstrasse 61, 4056 Basel, Switzerland.
PMID:
30733090
DOI:
10.1016/j.vaccine.2019.01.038
Free full text

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center